Cargando…

Different treatment efficacies and side effects of cytotoxic chemotherapy

Differences in efficacy and toxicity between Asian and Caucasian patients with lung cancer treated with systemic chemotherapy is increasingly recognised. This is a major concern in the clinical setting as it influences outcomes and affect international harmonization of drug development. Interindivid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Low-Jia, Chong, Qingyun, Wang, Lingzhi, Cher, Goh Boon, Soo, Ross A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article on Ethnic Difference in Lung Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399437/ https://www.ncbi.nlm.nih.gov/pubmed/32802458 http://dx.doi.org/10.21037/jtd.2019.08.63

Ejemplares similares

Ethnic difference in lung cancer: an important issue in a globalized society
por: Kawaguchi, Tomoya, et al.
Publicado: (2020)

Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?
por: Lee, Jiyun, et al.
Publicado: (2020)

Difference of background in research and clinical practice between USA and China
por: Wen, Yang, et al.
Publicado: (2020)

Difference of environment behind research and clinical practice between USA and Japan
por: Komiya, Takefumi, et al.
Publicado: (2020)

Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian)
por: Izumi, Motohiro, et al.
Publicado: (2020)

The prevalence and impact of risk factors for ethnic differences in loneliness
por: Visser, Marlies A., et al.
Publicado: (2016)

Ethnic differences in longitudinal latent verbal profiles in the millennium cohort study*
por: Zilanawala, Afshin, et al.
Publicado: (2016)

Ethnic and Regional Differences in the Management of Angina: The Way Forward
por: Barton, Jack C, et al.
Publicado: (2022)

Determinants of suboptimal blood pressure control in a multi‐ethnic population: The Healthy Life in an Urban Setting (HELIUS) study
por: van der Linden, Eva L., et al.
Publicado: (2021)

PD-1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in patients with advanced non-squamous non-small-cell lung cancer: a pooled analysis of three randomised trials
por: Meng, Xiangjiao, et al.
Publicado: (2022)

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data
por: Moskovitz, Mor, et al.
Publicado: (2022)

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States
por: Jahanzeb, Mohammad, et al.
Publicado: (2022)

Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy
por: Ishii, Hidenobu, et al.
Publicado: (2017)

A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy
por: Liu, Yutao, et al.
Publicado: (2020)

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B(12) and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
por: Minchom, A R, et al.
Publicado: (2014)

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRAS(G12C)-Mutant Non-Small Cell Lung Cancer
por: Elkrief, Arielle, et al.
Publicado: (2023)

A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
por: Marrone, Kristen A., et al.
Publicado: (2018)

LDCT lung cancer screening in populations at different risk for lung cancer
por: Teles, Gustavo Borges da Silva, et al.
Publicado: (2020)

Racial and Ethnic Differences in Neighborhood Attainments in the Transition to Adulthood
por: Swisher, Raymond R., et al.
Publicado: (2013)

Deep learning with test-time augmentation for radial endobronchial ultrasound image differentiation: a multicentre verification study
por: Yu, Kai-Lun, et al.
Publicado: (2023)

Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening
por: Kim, Yeon Wook, et al.
Publicado: (2021)

Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients
por: Møller, Henrik, et al.
Publicado: (2018)

IMPACT OF COVID-19 PANDEMIC ON DIAGNOSIS AND TREATMENT OF LUNG CANCER IN THE VETERAN COHORT
por: ABBAS, HATOON, et al.
Publicado: (2021)

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
por: Novello, Silvia, et al.
Publicado: (2023)

Initial experience with transbronchial cryoablation as a novel local treatment for malignant peripheral lung lesions
por: Kohno, Mitsutomo, et al.
Publicado: (2018)

Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
por: Taylor, Sally, et al.
Publicado: (2021)

Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review
por: Hall, Helen, et al.
Publicado: (2022)

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
por: Popat, Sanjay, et al.
Publicado: (2020)

Evaluation of cardiovascular risk in a lung cancer screening cohort
por: Ruparel, Mamta, et al.
Publicado: (2019)

Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey
por: Lammers, Austin, et al.
Publicado: (2018)

Potential applications of prognostic and immunological marker transmembrane serine proteinase 2 in prediction, prevention and personalized treatment of lung cancer
por: Mu, Bo, et al.
Publicado: (2022)

Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design
por: Aggarwal, Charu, et al.
Publicado: (2017)

Application of liquid biopsy-based targeted capture sequencing analysis to improve the precision treatment of non-small cell lung cancer by tyrosine kinase inhibitors
por: Zhang, Lei, et al.
Publicado: (2022)

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
por: Wang, Xiaofei, et al.
Publicado: (2017)

Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer
por: Batra, Ullas, et al.
Publicado: (2023)

Which is the best treatment on a 2 cm complete endophitic tumor on the posterior side of the left kidney?
por: Garcia, Rodrigo Gobbo
Publicado: (2016)

Which is the best treatment on a 2 cm complete endophitic tumor on the posterior side of the left kidney?
por: Arriaga, Juan, et al.
Publicado: (2016)

Minority stress factors as mediators of sexual orientation disparities in mental health treatment: a longitudinal population-based study
por: Bränström, Richard
Publicado: (2017)

Is investigation of patients with haemoptysis and normal chest radiograph justified?
por: Thirumaran, M, et al.
Publicado: (2009)

Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial
por: Ishida, Takashi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cjq9h3309p3aaeqoga0n5f6cli